Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,427 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05944016RecruitingPhase 3
Dapagliflozin for early Alport kidney disease in teens and young adults
This trial tests dapagliflozin, a daily medicine, to slow kidney problems in people with early-stage chronic kidney disease caused by Alport syndrome. It may help protect kidney function and reduce worsening over time.
Heidelberg, Baden-WürttenbergAges 10–39 - NCT06008392Recruiting
Mayo Clinic cancer genetics research study
This study collects blood, saliva, tumor tissue, or hair samples to look for inherited and tumor-related gene changes that may explain your cancer, guide prevention, or help find better treatments. You can join if you are a Mayo Clinic patient with cancer and your doctor has ordered genetic testing.
Scottsdale, ArizonaAges 18 years+ - NCT07137442Recruiting
Tic study: comparing tics and functional tics with brain tests
This study uses EEG and EMG tests to tell the difference between tics and functional tics. You may help doctors better understand and diagnose these conditions.
Bethesda, MarylandAges 18–80 - NCT07876635Recruiting
Knee tunnel placement study for ACL repair outcomes
This study looks at where the bone tunnel is placed during ACL reconstruction surgery and whether that placement affects how well the knee heals and functions after surgery. It could help doctors improve surgery techniques for better recovery.
SakaryaAges 18–50 - NCT06163430RecruitingPhase 1/Phase 2
Study of MK-4208 for chronic myeloid leukemia
This trial tests a new pill that may help people with chronic myeloid leukemia (CML) when other treatments have stopped working or caused side effects. It might offer another option for controlling the disease.
Birmingham, AlabamaAges 18 years+ - NCT07708961RecruitingPhase 2
Temozolomide with or without WSD0922-FU for EGFR-mutant glioblastoma
This trial tests whether adding a new drug, WSD0922-FU, to standard chemotherapy (temozolomide) works better than temozolomide alone for a specific type of glioblastoma that has an EGFR mutation. It is for patients who have completed radiation and temozolomide together but haven't started maintenance temozolomide yet.
Scottsdale, ArizonaAges 18 years+ - NCT07875478Recruiting
Tracking factor X deficiency to improve patient care
This study collects health information and blood samples from people with factor X deficiency (a rare bleeding disorder) and their close family members. The goal is to learn more about how the condition progresses over time, which could lead to better treatment and management.
FlorenceAges Any age - NCT07141251Recruiting
Custom stent-graft procedure for complex aortic aneurysm repair
This study tests a new way to repair a complex aortic aneurysm (a bulge in the main artery) using a special procedure that helps keep blood flowing to your vital organs. It may help people who are not candidates for standard surgery. The goal is to see if this approach is safe and works well.
Beijing, Beijing MunicipalityAges 18–80 - NCT07876050Recruiting
Relief from period symptoms with a daily natural supplement
This trial tests a daily supplement called the Kaia Relief - Cycle System to see if it reduces premenstrual symptoms like cramps, mood swings, and discomfort. It might help you manage your period-related symptoms better.
Las Vegas, NevadaAges 18–45 - NCT07877025Recruiting
Follicle flushing compared with direct aspiration for egg retrieval
This study compares two ways of collecting eggs from the ovaries during a procedure done through the abdomen, rather than through the vagina. It aims to see if flushing the follicle (washing out the egg) works better than directly sucking it out, which could help women who cannot or prefer not to have the usual vaginal procedure.
Ankara, AnkaraAges 18–42 - NCT07876167Recruiting
Ceramic crown performance with different surface treatments
This trial compares two methods of preparing ceramic crowns before placing them on back teeth. The goal is to see if a new gas-based treatment makes crowns stronger and last longer than the standard acid etch.
LjubljanaAges 18 years+ - NCT07298824RecruitingPhase 2
MR-61 eye drops for slowing nearsightedness in children
This trial tests an eye drop called MR-61 to see if it can slow down worsening nearsightedness (myopia) in children and teens. The study aims to find a safe and easy way to keep their vision from getting worse.
Nanchang, JiangxiAges 3–18 - NCT07875998Recruiting
Blood markers and symptoms in probable Alzheimer's dementia
This study looks at people with probable Alzheimer's disease to see how certain blood biomarkers relate to their symptoms. It may help doctors better understand the disease and tailor care.
Tianjin, Tianjin MunicipalityAges 55–90 - NCT07571837Recruiting
Nano-medication to reduce inflammation after root canal retreat
This study tests a special nano-sized (extremely tiny) medication placed inside a tooth after a previous root canal treatment failed. The goal is to reduce inflammation and swelling in the bone around the tooth's tip so it can heal better.
Cairo, Nasr CityAges 20–40 - NCT06832761Recruiting
Lifestyle help for people with early memory concerns
This trial tests whether a lifestyle program can help people with mild memory problems (subjective cognitive decline or mild cognitive impairment) who also have at least two things that increase their risk for dementia, like high blood pressure or lack of exercise. If you're 50 or older and have these memory issues and risk factors, you may be able to join.
AmsterdamAges 50 years+ - NCT06925737RecruitingPhase 3
Study of I-DXd for metastatic prostate cancer
This study tests a new drug called Ifinatamab Deruxtecan (I-DXd) for people with metastatic prostate cancer that has stopped responding to hormone therapy. It may help by targeting and destroying cancer cells in a different way.
Phoenix, ArizonaAges 18 years+ - NCT03019757Recruiting
Testing ways to tell dementia causes apart
This study looks at how to distinguish Alzheimer’s disease, Lewy body dementia, and Parkinson’s disease when someone has memory and thinking problems. It may help doctors choose the most accurate diagnosis and treatment path for the right condition.
Columbus, OhioAges 18 years+ - NCT05636969Recruiting
Pre-surgery exercise program for lung cancer treatment
This trial looks at whether a “prehabilitation” (guided exercise and fitness preparation) program helps people with non-small cell lung cancer get ready for surgery after starting treatment before surgery. It may help you tolerate treatment and surgery better if you can do the required fitness testing and procedures.
Barcelona, BarcelonaAges 18 years+ - NCT07785609RecruitingPhase 2
New drug combination for advanced solid tumors
This trial tests a new drug combination for people with advanced solid tumors. It aims to see if the combination is safe and may shrink tumors.
San Antonio, TexasAges 18 years+ - NCT06827236RecruitingPhase 1/Phase 2
Testing a new combination treatment for advanced breast cancer
This study tests two experimental drugs, BNT323 and BNT327, together in people with advanced breast cancer. The goal is to find the best dose and see if the combination is safe and helpful.
Beverly Hills, CaliforniaAges 18 years+ - NCT07490067RecruitingPhase 4
Metoprolol for heart failure: genes and drug response
This trial tests how the drug metoprolol works in people with heart failure and reduced pumping function. It looks at whether your genetic makeup affects how the drug is processed and how well it helps your heart.
Ann Arbor, MichiganAges 18 years+ - NCT07186842RecruitingPhase 1/Phase 2
Testing the safety of BNT329 for advanced CA19-9 positive tumors
This trial tests if the investigational drug BNT329 is safe and could help people with advanced solid tumors that make a marker called CA19-9. It is for those who have tried standard treatments and need new options.
Denver, ColoradoAges 18 years+ - NCT07600736RecruitingPhase 2
Safety study of ABS-1230 for children with KCNT1 epilepsy
This trial tests a new drug called ABS-1230 in children and young adults with KCNT1-related epilepsy, a rare genetic form of epilepsy. The study will check if the drug is safe and if it helps reduce seizures.
Hackensack, New JerseyAges 1 month–21 years - NCT07637500Recruiting
Tiny Eye Insert to Improve Close-up Vision
This trial tests a tiny device inserted into the eye to help people aged 45–60 who have trouble seeing up close. If you have good distance vision but struggle reading or seeing near objects, this study may help you see better without glasses for reading.
BochumAges 45–60
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,427 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.